Institution
National Institute of Pharmaceutical Education and Research
Recent research
- Engineering & Technology
Abstract The integration of microneedles (MNs) with electrochemical biosensors is a promising strategy for minimally invasive detection of metabolites from interstitial fluid (ISF). Conventional MN-based sensing platforms typically rely on conductive coatings or surface functiona...
- Health & Medicine
Introduction Ultrathin-strut drug-eluting stents (DES) have been developed to enhance vascular healing and reduce restenosis following percutaneous coronary intervention (PCI). Indigenous biodegradable-polymer ultrathin-strut DES are increasingly used in high-burden settings; how...
- Materials & Energy
Unsymmetrical ureas are valuable structural motifs in pharmaceuticals, agrochemicals, and functional materials; however, their synthesis often relies on toxic reagents, transition metals, or isocyanate intermediates, resulting in poor sustainability and limited scalability. Herei...
- Health & Medicine
Abstract Toll-like receptors (TLRs) are key pattern recognition receptors that play a central role in regulating and bridging both innate and adaptive immune responses. Notably, TLR7 and TLR8 agonists have gained significant attention as promising therapeutic candidates because o...
- Materials & Energy
Abstract Multicomponent crystalline systems offer a viable approach to improving the physicochemical and pharmacokinetic properties of drugs, thereby enabling the rational optimization of solid forms through coformer identification. The conventional process relies on empirical kn...
- Health & MedicineOpen access
Dopamine alters macrophage metabolism promoting intracellular Mycobacterium tuberculosis survival
Dopamine (DA) is thought to aggravate progress of bacterial infections and enhance risk of intracellular bacterial infection like tuberculosis (TB). Though TB patients are known to present with high dopamine levels the causal link between them has remained unexplored. Mycobacteri...
- Biology
Abstract Clinically approved therapies have established that combining β-lactam antibiotics with β-lactamase inhibitors is an effective strategy to counter antibiotic resistance; however, infections caused by metallo-β-lactamase (MBL) producing bacteria remain a critical unmet me...